ASSAY and Drug Development Technologies

Editor-in-Chief: Bruce Melancon, PhD

ISSN: 1540-658X | Online ISSN: 1557-8127 | 8 Issues Annually | Current Volume: 18

Impact Factor:* 1.187
*2019 Journal Citation Reports (Clarivate, 2020)

Delivering the latest industry insight into innovative early-stage research, techniques, and tools for optimizing new pharmaceutical development.

View Aims & Scope

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

Announcements

CALL FOR PAPERS: Special Issue on Drug Delivery Research

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.